MeiraGTx Holdings MGTX
NASDAQ MGTX
$13.89 -0.08 (-0.57%)
As of: Sep 4, 2026 · 3:59 PM EDT

MeiraGTx Holdings (MGTX) Cash from Operations (2017 - 2025)

MeiraGTx Holdings' (MGTX) quarterly Cash from Operations came in at 46631000.0 in Q4 2025, up 300.34% YoY from 11647866.63 in Q4 2024, and up 481.75% on a QoQ basis from 12215000.0 in Q3 2025.

Analysis

MeiraGTx Holdings (MGTX) Cash from Operations (2017 - 2025) Analysis & Trends

MeiraGTx Holdings (MGTX) has 9 years of Cash from Operations data on file, last reported at 46631000.0 in Q4 2025.

  • Quarterly Cash from Operations rose 300.34% year-over-year to 46631000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 46359000.0 (up 55.64% YoY) and the FY2025 annual result came in at 46359000.0, up 55.64% from the prior year.
  • Cash from Operations improved to 46631000.0 in Q4 2025, from 12215000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 46631000.0 in Q4 2025 to a low of 43975000.0 in Q2 2025.
  • A 5-year average of 16992350.0 and a median of 20993500.0 in 2021 frame the typical range for Cash from Operations.
  • Annual changes were most pronounced in 2023 — Cash from Operations plunged 350.61% — and 2025, when it jumped 300.34%.
  • Tracing MGTX's Cash from Operations over 5 years: stood at 18828000.0 in 2021, then sank by 186.4% to 16267000.0 in 2022, then rose by 10.57% to 14547000.0 in 2023, then slumped by 60.01% to 23276000.0 in 2024, then jumped by 300.34% to 46631000.0 in 2025.
  • The last three Cash from Operations figures came in at 46631000.0 (Q4 2025), 12215000.0 (Q3 2025), and 43975000.0 (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.13 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 813.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -526.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -387.32 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 462.82 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 326.72 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 728.46 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -88.83 Mn
10 MeiraGTx Holdings 1.27 Bn 1.13 Bn 315.67 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 46.60 Mn
Sep 30, 2025 -12.23 Mn
Jun 30, 2025 -43.95 Mn
Mar 31, 2025 -36.83 Mn
Dec 31, 2024 -23.28 Mn
Sep 30, 2024 -25.02 Mn
Jun 30, 2024 -19.46 Mn
Mar 31, 2024 -36.74 Mn
Dec 31, 2023 -14.55 Mn
Sep 30, 2023 -24.41 Mn
Jun 30, 2023 -29.01 Mn
Mar 31, 2023 -37.39 Mn
Dec 31, 2022 -16.27 Mn
Sep 30, 2022 -20.73 Mn
Jun 30, 2022 -27.81 Mn
Mar 31, 2022 -8.30 Mn
Dec 31, 2021 18.83 Mn
Sep 30, 2021 -17.18 Mn
Jun 30, 2021 -21.26 Mn
Mar 31, 2021 9.09 Mn